<DOC>
	<DOCNO>NCT00002774</DOCNO>
	<brief_summary>PURPOSE : Randomized phase 2 trial compare effectiveness chemo-radiation therapy ( RT + cisplatin + 5-FU ) without tirapazamine treatment patient stage III IV squamous cell carcinoma head neck cancer ( SCCHN ) . RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . Radiation therapy use high-energy x-rays damage tumor cell . Tirapazamine may increase effectiveness chemotherapy radiation therapy make tumor cell sensitive therapy .</brief_summary>
	<brief_title>Radiation Therapy Combination Chemotherapy Treating Patients With Stage III Stage IV Head Neck Cancer</brief_title>
	<detailed_description>Subjects stratify accord pO2 value ( high vs low ) , randomize 1 2 treatment arm , differ addition tirapazamine therapeutic regimen . Treatment consist two 21-day cycle induction chemotherapy , follow radiotherapy ( RT ) . Induction chemotherapy cisplatin 100 mg/m2 per day administer 4 hour Study Days 1 22 ( ie , 1st day induction cycle ) continuous infusion ( CI ) 5-FU dose 1000 mg/m2 per day 120 hour per cycle start Study Days 1 22 ( ie , day 1 5 induction cycle ) . Patients achieve least partial response proceed chemoradiotherapy ( CRT ) consist localize RT + cisplatin IV + 5-FU +/- tirapazamine . Location RT base whether site CR PR . Radiotherapy begin day 43 ( week 1 ) , continue 5.5 week . Subjects response progressive disease proceed salvage surgery . A total 63 patient accrue study approximately 5 year . 1 subject withdraw consent prior treatment personal reason .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Tirapazamine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsy proven squamous cell carcinoma follow head neck site : Hypopharynx Oral cavity Larynx Oropharynx Nasal cavity Unknown primary Paranasal sinus Histologically proven poorlydifferentiated carcinoma follow head neck site : Hypopharynx Oral cavity Larynx Oropharynx Nasal cavity Paranasal sinus Stage III/IV ( T04 N13 M02 ) disease PATIENT CHARACTERISTICS : WBC least 3,000/mm3 Bilirubin great 2.0 mg/dL AST great 100 U/L Creatinine great 2.0 mg/dL Creatinine clearance least 60 mL/min ( patient Group N2N3 ) No second malignancy within 5 year except curatively treat nonmelanomatous skin carcinoma No prior RT chemotherapy , except prior radiotherapy primary tumor allow Not pregnant nursing . Negative pregnancy test require Effective contraception require fertile woman Subjects unknown primary cancer metastatic cervical lymph node eligible Signed informed consent previously approve Institutional Review Board .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>stage III</keyword>
	<keyword>stage IV</keyword>
	<keyword>recurrent</keyword>
</DOC>